Company size
For company-size screening, a 20–29 employee company falls below micro1’s published 30+ target. Protege must be scoped against its own eligibility description; silence is not acceptance.
Direct licensing meets specialist licensing. Neither advertised amounts nor a public seller route establish what your business will receive.
Jump to the terms ledger ↓Research comparison; limited public terms. Pair-level evidence and scenario review is pending. Published fields alone do not meet our indexing threshold. This page is noindex and absent from the sitemap, not a negative verdict.
| Criterion | micro1 | Protege |
|---|---|---|
| Operating records | Published SOPs, knowledge bases, CRM, projects, QA and internal processes Source ↗ | Published Healthcare, video, audio/speech, spatial/physical and other domains; generic CRM/SOP archives not explicitly enumerated Source ↗ |
| Company eligibility | Published 30+ employees; established documentation; English documents and representatives. Source ↗ | Published Typically owns outright or controls broad global/all-media rights; quality and opportunity-specific qualification. Source ↗ |
| Seller geography | Published US prioritized, then Western markets; strongest current demand US/UK/Canada. Global referrals do not mean global acceptance. Source ↗ | Unknown Not published / not established Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted. |
| Published compensation | Provider claim $100k+, $500k+, $1M+ advertised partnership tiers. USD context; period unspecified; individually evaluated, not guaranteed. Source ↗ | Provider claim Negotiated revenue share. Gradient Health seven-figure revenue is a provider-hosted specialist case, not an ordinary business rate. Source ↗ |
| Fees & net proceeds | Unknown Not published / not established Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted. | Unknown Not published / not established Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted. |
| Timeline & payment trigger | Unknown Not published / not established Not established in inspected sources: No quantified payment timeline published. Ask the provider; missing terms do not establish acceptance, free fees or a payment deadline. Inspection URLs remain in the profile source list. | Provider claim Active opportunities often fulfilled under a month; fulfillment is not seller payment timing. Source ↗ |
| Preparation & seller effort | Published Evaluation → discovery → agreed requirements → partnership. Source ↗ | Published Discovery → revenue-share agreement → curate/QA/mask → qualified deal → revenue-share payment. Source ↗ |
| Ownership & permitted use | Published Retains underlying ownership; approvals and scope agreed before participation. Source ↗ | Published Retains ownership; limited defined AI training/fine-tuning/evaluation/benchmarking rights; no public exhibition/redistribution/entertainment use. Source ↗ |
| Privacy & approval | Provider claim PII removed when relevant; samples reviewable; isolated processing and authorized access. Source ↗ | Provider claim Identifier removal and jurisdiction-specific workflows; optional anonymization/voice modification. Media FAQ is not a universal operating-data contract. Source ↗ |
| Exclusivity | Unknown Not published / not established Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted. | Unknown Not published / not established Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted. |
| Retention & deletion | Published Retention/deletion follow agreed terms; no public exact duration. Source ↗ | Unknown Not published / not established Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted. |
| HQ / published contact | Published Published privacy contact: San Francisco, US; operational HQ not independently established. Source ↗ | Published Published contact: New York, NY, US; not independently verified operational HQ. Source ↗ |
For company-size screening, a 20–29 employee company falls below micro1’s published 30+ target. Protege must be scoped against its own eligibility description; silence is not acceptance.
For specialist healthcare or media rights, Protege's published categories and Gradient Health case are more relevant than ordinary CRM exports. micro1 lists SOPs, knowledge bases, CRM, projects, QA and internal processes. Do not extrapolate specialist case revenue to a small operating business.
micro1: Payment timing not established; ask the provider. Protege: Active opportunities often fulfilled under a month; fulfillment is not seller payment timing. These clocks measure different stages, not equivalent payout deadlines; ask for a written acceptance-to-payment interval.
Both routes need lawful rights to the material. Removing names does not remove confidentiality obligations or re-identification risk. Require sample approval, buyer-use restrictions, precise payment triggers and downstream retention/deletion terms.
micro1: No independently audited operating-business payout established in this research. Provider cases and partnership confirmations do not establish a typical seller outcome.
Protege: Gradient Health seller-hosted announcement corroborates partnership and imaging supply, not revenue. Provider-hosted case claims seven-figure revenue; no independently audited receipt.